Jingtao Wu

1.1k total citations
44 papers, 851 citations indexed

About

Jingtao Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cognitive Neuroscience. According to data from OpenAlex, Jingtao Wu has authored 44 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cognitive Neuroscience. Recurrent topics in Jingtao Wu's work include Functional Brain Connectivity Studies (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). Jingtao Wu is often cited by papers focused on Functional Brain Connectivity Studies (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). Jingtao Wu collaborates with scholars based in China, United States and United Kingdom. Jingtao Wu's co-authors include Darcy J. Mulford, Hongying Zhang, Ronald Lee, Majid Vakily, Haishan Yang, Andrew L. Frelinger, Julie K. Brooks, Sai Nudurupati, Anu Nigam and Yong He and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Jingtao Wu

44 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingtao Wu China 15 195 195 180 172 107 44 851
Yeu‐Sheng Tyan Taiwan 17 196 1.0× 63 0.3× 35 0.2× 156 0.9× 73 0.7× 90 851
Shinichi Hamada Japan 14 169 0.9× 32 0.2× 173 1.0× 212 1.2× 93 0.9× 32 802
Naoki Matsumoto Japan 19 122 0.6× 31 0.2× 241 1.3× 268 1.6× 71 0.7× 70 984
Glaucylara Reis Geovanini Brazil 9 118 0.6× 36 0.2× 234 1.3× 212 1.2× 45 0.4× 14 841
Dianne J. Delsing Netherlands 17 253 1.3× 35 0.2× 86 0.5× 197 1.1× 78 0.7× 28 841
Xiaoyi Li China 16 238 1.2× 15 0.1× 56 0.3× 145 0.8× 489 4.6× 88 848
Andrea Richards United Kingdom 12 75 0.4× 52 0.3× 56 0.3× 100 0.6× 30 0.3× 26 667
José Pavı́a Spain 18 122 0.6× 18 0.1× 100 0.6× 299 1.7× 30 0.3× 49 1.0k
Mine Kinoshita Japan 18 141 0.7× 13 0.1× 40 0.2× 282 1.6× 30 0.3× 35 769

Countries citing papers authored by Jingtao Wu

Since Specialization
Citations

This map shows the geographic impact of Jingtao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingtao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingtao Wu more than expected).

Fields of papers citing papers by Jingtao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingtao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingtao Wu. The network helps show where Jingtao Wu may publish in the future.

Co-authorship network of co-authors of Jingtao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingtao Wu. A scholar is included among the top collaborators of Jingtao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingtao Wu. Jingtao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Jianxin, Jingtao Wu, Zhu Yu, & Xiaojun Gao. (2025). Investigation on Seed-Filling Effect of Quantitative Precision Filling High-Speed Seed-Metering Device for Maize. Agriculture. 15(14). 1517–1517. 1 indexed citations
2.
Mei, Yayuan, Ang Li, Jiaxin Zhao, et al.. (2024). Disturbed glucose homeostasis and its increased allostatic load in response to individual, joint and fluctuating air pollutants exposure: Evidence from a longitudinal study in prediabetes. The Science of The Total Environment. 951. 175498–175498. 1 indexed citations
3.
Dong, Jianxin, Shilin Zhang, Zhouzhou Zheng, et al.. (2024). Development of a novel perforated type precision metering device for efficient and cleaner production of maize. Journal of Cleaner Production. 443. 140928–140928. 19 indexed citations
4.
Li, Kai, Jing Xu, Meiduo Zhao, et al.. (2023). Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis. Frontiers in Aging Neuroscience. 15. 1102762–1102762. 1 indexed citations
5.
Watts, Amber, Stephen Haneline, Kathleen A. Welsh‐Bohmer, et al.. (2023). TOMM40 ‘523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOE ɛ3 Homozygotes. Journal of Alzheimer s Disease. 95(4). 1697–1707. 1 indexed citations
6.
Liu, Hao, Jie Li, Jingtao Wu, et al.. (2023). Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study. Frontiers in Pharmacology. 14. 1199031–1199031. 18 indexed citations
7.
Zhou, Sichun, Duo Li, Di Xiao, et al.. (2022). Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage. International Journal of Biological Sciences. 18(4). 1555–1568. 28 indexed citations
8.
Zhou, Sichun, Mei Qin, Jing Tang, et al.. (2021). Phenformin and ataxia‐telangiectasia mutated inhibitors synergistically co‐suppress liver cancer cell growth by damaging mitochondria. FEBS Open Bio. 11(5). 1440–1451. 5 indexed citations
9.
Ferdinand, Keith C., George L. Bakris, William C. Cushman, et al.. (2018). Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension. The American Journal of Cardiology. 122(9). 1496–1505. 4 indexed citations
10.
Juhász, Attila, et al.. (2018). Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension. Clinical Hypertension. 24(1). 2–2. 6 indexed citations
11.
Qian, Mark G., et al.. (2016). Rapid quantification of a cleavable antibody-conjugated drug by liquid chromatography/tandem mass spectrometry with microwave-assisted enzymatic cleavage. Journal of Pharmaceutical and Biomedical Analysis. 128. 226–235. 10 indexed citations
12.
13.
Wu, Jingtao. (2011). STUDY ON THE RELATIONSHIP BETWEEN POPULATION AND ECONOMIC SPATIAL DISTRIBUTION AND ITS DYNAMIC IN CHONGQING. Economic Geography. 5 indexed citations
14.
Wu, Jingtao, Huizhen Wu, Chao‐Gan Yan, et al.. (2011). Aging-related changes in the default mode network and its anti-correlated networks: A resting-state fMRI study. Neuroscience Letters. 504(1). 62–67. 102 indexed citations
15.
Frelinger, Andrew L., Deepak L. Bhatt, Ronald Lee, et al.. (2011). CLOPIDOGREL PHARMACOKINETICS AND PHARMACODYNAMICS VARY WIDELY, INDEPENDENT OF CYP2C19 POLYMORPHISMS, DIET, SMOKING, PROTON PUMP INHIBITORS AND OTHER CO-MEDICATIONS. Journal of the American College of Cardiology. 57(14). E927–E927. 1 indexed citations
16.
Vakily, Majid, Jingtao Wu, & Stuart Atkinson. (2009). Lack of Electrocardiographic Effect of Dexlansoprazole MR, a Novel Modified‐Release Formulation of the Proton Pump Inhibitor Dexlansoprazole, in Healthy Participants. The Journal of Clinical Pharmacology. 49(12). 1447–1455. 6 indexed citations
17.
18.
Vakily, Majid, Ronald Lee, Jingtao Wu, Lhanoo Gunawardhana, & Darcy J. Mulford. (2008). Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation. Clinical Drug Investigation. 29(1). 35–50. 24 indexed citations
19.
Wu, Jingtao. (2007). Research and Experiment of Wide-area Stability Control Techniques in Electric Power Systems. Nanfang dianwang jishu. 3 indexed citations
20.
Shi, Junxing, Judy S. Mathew, Phillip M. Tharnish, et al.. (2003). N4-Acyl-Modified D-2′,3′-Dideoxy-5-Fluorocytidine Nucleoside Analogues with Improved Antiviral Activity. Antiviral chemistry & chemotherapy. 14(2). 81–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yeu‐Sheng Tyan Breakdown of academic impact, for papers by Shinichi Hamada Breakdown of academic impact, for papers by Naoki Matsumoto Breakdown of academic impact, for papers by Glaucylara Reis Geovanini Breakdown of academic impact, for papers by Dianne J. Delsing Breakdown of academic impact, for papers by Xiaoyi Li Breakdown of academic impact, for papers by Andrea Richards Breakdown of academic impact, for papers by José Pavı́a Breakdown of academic impact, for papers by Mine Kinoshita
Rankless by CCL
2026